Buy One Get One free -Llimited Time Offer X
Telplus Trio 40/10/6.25 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Telplus Trio 40/10/6.25 Tablet have also been mentioned below.
The correct dosage of Telplus Trio 40/10/6.25 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Telplus Trio 40/10/6.25 Tablet include Back Pain, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Telplus Trio 40/10/6.25 Tablet as well, which are listed below. Such side effects of Telplus Trio 40/10/6.25 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Telplus Trio 40/10/6.25 Tablet's effect is Mild during pregnancy and Mild for lactating mothers. Further, the section on Telplus Trio 40/10/6.25 Tablet related warnings talks about Telplus Trio 40/10/6.25 Tablet's effects on the liver, heart and kidney.
Telplus Trio 40/10/6.25 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia as it can result in adverse effects. Some other conditions that can be affected by Telplus Trio 40/10/6.25 Tablet are listed in the contraindications section below.
Drug interactions for Telplus Trio 40/10/6.25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Telplus Trio 40/10/6.25 Tablet is considered not safe while driving, and is not addictive.
Telplus Trio 40/10/6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telplus Trio 40/10/6.25 Tablet safe for pregnant women?
Pregnant women may get mild side effects from Telplus Trio.
Is the use of Telplus Trio 40/10/6.25 Tablet safe during breastfeeding?
Side effects of Telplus Trio on breastfeeding women are very mild.
What is the effect of Telplus Trio 40/10/6.25 Tablet on the Kidneys?
Telplus Trio rarely harms the kidneys.
What is the effect of Telplus Trio 40/10/6.25 Tablet on the Liver?
Very few cases of side effects of Telplus Trio on the liver have been reported.
What is the effect of Telplus Trio 40/10/6.25 Tablet on the Heart?
Side effects of Telplus Trio rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Telplus Trio 40/10/6.25 Tablet unless your doctor advises you to do so -
Is this Telplus Trio 40/10/6.25 Tablet habit forming or addictive?
Forming a habit of Telplus Trio 40/10/6.25 Tablet has not been reported.
Interaction between Food and Telplus Trio 40/10/6.25 Tablet
Some foods when eaten with Telplus Trio 40/10/6.25 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Telplus Trio 40/10/6.25 Tablet
Consumption of alcohol and Telplus Trio 40/10/6.25 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448